Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Schrier

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Anti-inflammatory properties of Gö 6850: a selective inhibitor of protein kinase CP B Jacobson, S L Kuchera, A Metz, et al.
Journal of Medicinal Chemistry|October 2, 1992
Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitorsP C Unangst, G P Shrum, D T Connor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1981
Strain variation in BCG-induced chronic pulmonary inflammation in mice: control by a cyclophosphamide-sensitive thymus-derived suppressor cellV L Moore, V M Mondloch, G M Pedersen, et al.
Arthritis and Rheumatism|August 1, 1996
The effects of the phospholipase A2 inhibitor, manoalide, on cartilage degradation, stromelysin expression, and synovial fluid cell count induced by intraarticular injection of human recombinant interleukin-1 alpha in the rabbitD J Schrier, C M Flory, M Finkel, et al.
Journal of Medicinal Chemistry|April 16, 1993
Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally-active, nonulcerogenic antiinflammatory agentsM D Mullican, M W Wilson, D T Connor, et al.
Agents and Actions|August 1, 1987
Preliminary report on 8-amino-9-(2-thienylmethyl)guanine (PD 119,229), a novel and potent purine nucleoside phosphorylase inhibitorR B Gilbertsen, M E Scott, M K Dong, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1992
The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP)M K Dong, M E Scott, D J Schrier, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 1996
Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee jointC M Flory, P A Pavco, T C Jarvis, et al.
Osteoarthritis and Cartilage|November 12, 2003
Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritisS E Bove, S L Calcaterra, R M Brooker, et al.
Journal of Medicinal Chemistry|January 21, 1994
Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethylethyl)- 4-hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles: novel dual 5-lipoxygenase and cyclooxygenase inhibitors with antiinflammatory activityP C Unangst, D T Connor, W A Cetenko, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Anti-inflammatory properties of Gö 6850: a selective inhibitor of protein kinase CP B Jacobson, S L Kuchera, A Metz, et al.
Journal of Medicinal Chemistry|October 2, 1992
Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitorsP C Unangst, G P Shrum, D T Connor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1981
Strain variation in BCG-induced chronic pulmonary inflammation in mice: control by a cyclophosphamide-sensitive thymus-derived suppressor cellV L Moore, V M Mondloch, G M Pedersen, et al.
Arthritis and Rheumatism|August 1, 1996
The effects of the phospholipase A2 inhibitor, manoalide, on cartilage degradation, stromelysin expression, and synovial fluid cell count induced by intraarticular injection of human recombinant interleukin-1 alpha in the rabbitD J Schrier, C M Flory, M Finkel, et al.
Journal of Medicinal Chemistry|April 16, 1993
Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally-active, nonulcerogenic antiinflammatory agentsM D Mullican, M W Wilson, D T Connor, et al.
Agents and Actions|August 1, 1987
Preliminary report on 8-amino-9-(2-thienylmethyl)guanine (PD 119,229), a novel and potent purine nucleoside phosphorylase inhibitorR B Gilbertsen, M E Scott, M K Dong, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1992
The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP)M K Dong, M E Scott, D J Schrier, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 1996
Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee jointC M Flory, P A Pavco, T C Jarvis, et al.
Osteoarthritis and Cartilage|November 12, 2003
Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritisS E Bove, S L Calcaterra, R M Brooker, et al.
Journal of Medicinal Chemistry|January 21, 1994
Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethylethyl)- 4-hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles: novel dual 5-lipoxygenase and cyclooxygenase inhibitors with antiinflammatory activityP C Unangst, D T Connor, W A Cetenko, et al.
Pageof 4